Identification of rare variants in the hLIMD1 gene in breast cancer

Cancer Genetics and Cytogenetics

Volumn 178, Issue 1, 2007, Pages 36-41

  Huggins, Christopher J ^a,b   Gill, Mona ^b   Andrulis, Irene L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST TUMOR; CHROMOSOME 3P; CHROMOSOME DELETION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 3; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSPECTIVE STUDIES; VARIATION (GENETICS);

EID: 34548700592     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.06.007     Document Type: Article

References (40)

1. Kholodnyuk I., Kost-Alimova M., Kashuba V., Gizatulin R., Szeles A., Stanbridge E.J., Zabarovsky E.R., Klein G., and Imreh S. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice. Genes Chromosomes Cancer 18 (1997) 200-211
2. Szeles A., Yang Y., Sandlund A.M., Kholodnyuk I., Kiss H., Kost-Alimova M., Zabarovsky E.R., Stanbridge E., Klein G., and Imreh S. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes Chromosomes Cancer 20 (1997) 329-336
3. Imreh S., Kholodnyuk I., Allikmetts R., Stanbridge E.J., Zabarovsky E.R., and Klein G. Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice. Genes Chromosomes Cancer 11 (1994) 237-245
4. Yang Q., Yoshimura G., Mori I., Sakurai T., and Kakudo K. Chromosome 3p and breast cancer. J Hum Genet 47 (2002) 453-459
5. Maitra A., Wistuba II, Washington C., Virmani A.K., Ashfaq R., Milchgrub S., Gazdar A.F., and Minna J.D. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 159 (2001) 119-130
6. Zabarovsky E.R., Lerman M.I., and Minna J.D. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21 (2002) 6915-6935
7. Petursdottir T.E., Thorsteinsdottir U., Jonasson J.G., Moller P.H., Huiping C., Bjornsson J., Egilsson V., Imreh S., and Ingvarsson S. Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues. Genes Chromosomes Cancer 41 (2004) 232-242
8. Ji L., Minna J.D., and Roth J.A. 3p21.3 tumor suppressor cluster: prospects for translational applications. Future Oncol 1 (2005) 79-92
9. Kiss H., Kedra D., Yang Y., Kost-Alimova M., Kiss C., O'Brien K.P., Fransson I., Klein G., Imreh S., and Dumanski J.P. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum Genet 105 (1999) 552-559
10. Kadrmas J.L., and Beckerle M.C. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5 (2004) 920-931
11. Macalma T., Otte J., Hensler M.E., Bockholt S.M., Louis H.A., Kalff-Suske M., Grzeschik K.H., von der Ahe D., and Beckerle M.C. Molecular characterization of human zyxin. J Biol Chem 271 (1996) 31470-31478
12. Goyal R.K., Lin P., Kanungo J., Payne A.S., Muslin A.J., and Longmore G.D. Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner. Mol Cell Biol 19 (1999) 4379-4389
13. Petit M.M., Mols R., Schoenmakers E.F., Mandahl N., and Van de Ven W.J. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics 36 (1996) 118-129
14. Yi J., and Beckerle M.C. The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 49 (1998) 314-316
15. Srichai M.B., Konieczkowski M., Padiyar A., Konieczkowski D.J., Mukherjee A., Hayden P.S., Kamat S., El-Meanawy M.A., Khan S., Mundel P., Lee S.B., Bruggeman L.A., Schelling J.R., and Sedor J.R. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 279 (2004) 14398-14408
16. Tatarelli C., Linnenbach A., Mimori K., and Croce C.M. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics 68 (2000) 1-12
17. Shibanuma M., Mashimo J., Kuroki T., and Nose K. Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269 (1994) 26767-26774
18. Tu Y., Wu S., Shi X., Chen K., and Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 113 (2003) 37-47
19. Hansen M.D., and Beckerle M.C. Opposing roles of zyxin/LPP ACTA repeats and the LIM domain region in cell-cell adhesion. J Biol Chem 281 (2006) 16178-16188
20. Marie H., Pratt S.J., Betson M., Epple H., Kittler J.T., Meek L., Moss S.J., Troyanovsky S., Attwell D., Longmore G.D., and Braga V.M. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem 278 (2003) 1220-1228
21. Petit M.M., Meulemans S.M., Alen P., Ayoubi T.A., Jansen E., and Van de Ven W.J. The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus. BMC Cell Biol 6 (2005) 1
22. Nix D.A., Fradelizi J., Bockholt S., Menichi B., Louvard D., Friederich E., and Beckerle M.C. Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 276 (2001) 34759-34767
23. Hagmann J., Grob M., Welman A., van Willigen G., and Burger M.M. Recruitment of the LIM protein hic-5 to focal contacts of human platelets. J Cell Sci 111 Pt. 15 (1998) 2181-2188
24. Petit M.M., Meulemans S.M., and Van de Ven W.J. The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein. J Biol Chem 278 (2003) 2157-2168
25. Sharp T.V., Munoz F., Bourboulia D., Presneau N., Darai E., Wang H.W., Cannon M., Butcher D.N., Nicholson A.G., Klein G., Imreh S., and Boshoff C. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci USA 101 (2004) 16531-16536
26. Andrulis I.L., Bull S.B., Blackstein M.E., Sutherland D., Mak C., Sidlofsky S., Pritzker K.P., Hartwick R.W., Hanna W., Lickley L., Wilkinson R., Qizilbash A., Ambus U., Lipa M., Weizel H., Katz A., Baida M., Mariz S., Stoik G., Dacamara P., Strongitharm D., Geddie W., and McCready D. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16 (1998) 1340-1349
27. Knight J.A., Sutherland H.J., Glendon G., Boyd N.F., and Andrulis I.L. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. Ann Epidemiol 12 (2002) 27-33
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
29. Gokgoz N., Wunder J.S., Mousses S., Eskandarian S., Bell R.S., and Andrulis I.L. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 92 (2001) 2181-2189
30. Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., and Peters E.C. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem 76 (2004) 2763-2772
31. Hirota T., Morisaki T., Nishiyama Y., Marumoto T., Tada K., Hara T., Masuko N., Inagaki M., Hatakeyama K., and Saya H. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol 149 (2000) 1073-1086
32. Hirota T., Kunitoku N., Sasayama T., Marumoto T., Zhang D., Nitta M., Hatakeyama K., and Saya H. Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114 (2003) 585-598
33. Senchenko V.N., Liu J., Loginov W., Bazov I., Angeloni D., Seryogin Y., Ermilova V., Kazubskaya T., Garkavtseva R., Zabarovska V.I., Kashuba V.I., Kisselev L.L., Minna J.D., Lerman M.I., Klein G., Braga E.A., and Zabarovsky E.R. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23 (2004) 5719-5728
34. Lerman M.I., and Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60 (2000) 6116-6133
35. Kleer C.G., Giordano T.J., Braun T., and Oberman H.A. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Mod Pathol 14 (2001) 185-190
36. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., and Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25 (2000) 315-319
37. Dreijerink K., Braga E., Kuzmin I., Geil L., Duh F.M., Angeloni D., Zbar B., Lerman M.I., Stanbridge E.J., Minna J.D., Protopopov A., Li J., Kashuba V., Klein G., and Zabarovsky E.R. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98 (2001) 7504-7509
38. Xiang R., Davalos A.R., Hensel C.H., Zhou X.J., Tse C., and Naylor S.L. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 62 (2002) 2637-2643
39. Futamura M., Kamino H., Miyamoto Y., Kitamura N., Nakamura Y., Ohnishi S., Masuda Y., and Arakawa H. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res 67 (2007) 1451-1460
40. Feng Y., Zhao H., Luderer H.F., Epple H., Ross F.P., Teitelbaum S.L., and Longmore G.D. The LIM protein, LIMD1, regulates AP-1 activation through an interaction with TRAF6 to influence osteoclast development. J Biol Chem 282 (2006) 39-48